Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


CEREBAIN BIOTECH CORP. (CBBT) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/03/2021 REVOKED Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]:
01/27/2021 SC 13G/A EMA Financial, LLC reports a 9.9% stake in CEREBAIN BIOTECH CORP
02/13/2020 SC 13G/A EMA Financial, LLC reports a 9.9% stake in CEREBAIN BIOTECH CORP
10/01/2019 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
07/23/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Letter of Resignation of Mr. Wesley D. Tate"
05/20/2019 10-Q Quarterly Report for the period ended March 31, 2019
05/16/2019 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
04/22/2019 DEF 14C Form DEF 14C - Other definitive information statements:
04/05/2019 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form Certificate of Designation",
"Form of 12% Convertible Promissory Note issued March 15, 2019, to Auctus Fund, LLC",
"Form of Securities Purchase Agreement dated March 15, 2019, by and between Cerebain Biotech Corp. and Auctus Fund, LLC",
"Form of Common Stock Purchase Warrant dated March 1, 2019, issued to Auctus Fund LLC",
"Form of Common Stock Purchase Warrant dated March 1, 2019, issued to Crown Bridge Partners, LLC",
"Form of Amendment to the Convertible Promissory Note issued March 26, 2019, to Auctus Fund LLC",
"Form of Amendment to the Convertible Promissory Note issued February 14, 2018, to Crown Bridge Partners, LLC"
04/05/2019 PRE 14C Form PRE 14C - Other preliminary information statements:
02/19/2019 10-Q Quarterly Report for the period ended December 31, 2018
02/15/2019 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
02/14/2019 SC 13G EMA Financial, LLC reports a 9.9% stake in CEREBAIN BIOTECH CORP
12/26/2018 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Securities Purchase Agreement",
"Convertible Promissory Note"
11/14/2018 10-Q Quarterly Report for the period ended September 30, 2018
09/26/2018 10-K Annual Report for the period ended June 30, 2018
09/25/2018 4 CLEMONS ERIC (President) has filed a Form 4 on CEREBAIN BIOTECH CORP.
Txns: Granted 160,000 shares @ $0.18, valued at $28.8k
09/25/2018 4 Tate Wesley D. (CFO) has filed a Form 4 on CEREBAIN BIOTECH CORP.
Txns: Granted 160,000 shares @ $0.18, valued at $28.8k
05/15/2018 10-Q Quarterly Report for the period ended March 31, 2018
02/06/2018 10-Q Quarterly Report for the period ended December 31, 2017
11/09/2017 10-Q Quarterly Report for the period ended September 30, 2017
09/15/2017 10-K Annual Report for the period ended June 30, 2017
08/04/2017 8-K Quarterly results
05/11/2017 10-Q Quarterly Report for the period ended March 31, 2017
02/10/2017 10-Q Quarterly Report for the period ended December 31, 2016
11/14/2016 10-Q Quarterly Report for the period ended September 30, 2016
09/27/2016 10-K Annual Report for the period ended June 30, 2016
06/16/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/15/2016 4 Tate Wesley D. (CFO) has filed a Form 4 on CEREBAIN BIOTECH CORP.
Txns: Granted 150,000 shares @ $0.27, valued at $40.5k
Granted 150,000 shares @ $0.3, valued at $45k
05/16/2016 10-Q Quarterly Report for the period ended March 31, 2016
04/22/2016 8-K Form 8-K - Current report
02/22/2016 10-Q Quarterly Report for the period ended December 31, 2015
02/22/2016 10-K/A Annual Report for the period ended June 30, 2015 [amend]
11/16/2015 10-Q Quarterly Report for the period ended September 30, 2015
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy